ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2026; 51(1): 156-159


Novel insights into the efficacy of Itone Vs. Hylo eye drops in tear film instability of keratoconus

Kainat Ayub Kullachi, Memuna Nadeem, Hafiza Umm E Ammara, Muhammad Hannan Jamil, Khalid Rafique, Tahir Shaukat.



Abstract
Download PDF Post

Objective: To test the efficacy of Itone herbal eye drops compared to Hylo eye drops in increasing the tear film stability of patients with mild to moderate cases of Keratoconus.
Methodology: This quasi-experimental study was conducted at the Teaching Hospital, University of Lahore from April to August 2025. Purposive sampling was used to select 38 patients (76 eyes) with mild to moderate severity of keratoconus (K readings: 48–54 D) aged 15–35 years. Patients with severe keratoconus, other ocular/systemic pathology, or undergone ocular surgery previously or were under medication that influences the tear film were excluded. The sample was split into two groups (one was treated with Hylo eyedrops, and another with Itone herbal eyedrops), both administered three times a day. The data were analyzed by SPSS 26 with the help of the Wilcoxon and Mann-Whitney U tests.
Results: Out of the 38 participants, 21 (55.3%) were male and 17 (44.7) were female, with a mean age of 26±4.26 years (range: 18-34 years). Within the Itone group, the mean Ocular Surface Disease Index (OSDI) score dropped to 12.29±1.39 (range: 10.00-18.00) with two weeks of treatment as compared to the baseline level of 30.13 and 2.60 (range: 25.00-36.00) (p

Key words: Keratoconus, tear film, tear break up time, ocular surface disease index, artificial tears.





Bibliomed Article Statistics

13
R
E
A
D
S

11
D
O
W
N
L
O
A
D
S
02
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.